{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:02:55Z","timestamp":1784322175088,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jaad.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jaad.2018.05.023","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T16:38:22Z","timestamp":1527093502000},"page":"1550-1555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Potential of narrow-band ultraviolet B to induce sustained durable complete remission off-therapy in patients with stage I mycosis fungoides"],"prefix":"10.1016","volume":"80","author":[{"given":"Felix","family":"Pavlotsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Dawood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviv","family":"Barzilai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2018.05.023_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1468-3083.2006.01557.x","article-title":"UVB in the management of early stage mycosis fungoides","volume":"20","author":"Pavlotsky","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2018.05.023_bib2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s11899-017-0387-9","article-title":"Multidisciplinary management of mycosis fungoides\/S\u00e9zary syndrome","volume":"12","author":"Berg","year":"2017","journal-title":"Curr Hematol Malig Rep"},{"issue":"1","key":"10.1016\/j.jaad.2018.05.023_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2015.09.033","article-title":"Guidelines for phototherapy of mycosis fungoides and S\u00e9zary syndrome: a consensus statement of the United States Cutaneous Lymphoma Consortium","volume":"74","author":"Olsen","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2018.05.023_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archdermatol.2011.98","article-title":"The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides","volume":"147","author":"Navi","year":"2011","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2018.05.023_bib5","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.clml.2017.06.015","article-title":"Bath psoralen-ultraviolet A and narrowband ultraviolet B phototherapy as initial therapy for early-stage mycosis fungoides: a retrospective cohort of 267 cases at the University of Toronto","volume":"17","author":"Almohideb","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jaad.2018.05.023_bib6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","article-title":"Defining early mycosis fungoides","volume":"53","author":"Pimpinelli","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.05.023_bib7","first-page":"22","article-title":"Strategies for treating cutaneous T-cell lymphoma","volume":"2","author":"Latkowski","year":"2009","journal-title":"J Clin Aesthet Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2018.05.023_bib8","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/archderm.1996.03890350051009","article-title":"Clinical stage IA (limited patch and plaque) mycosis fungoides. a long-term outcome analysis","volume":"132","author":"Kim","year":"1996","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2018.05.023_bib9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0190-9622(99)70491-3","article-title":"Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients","volume":"40","author":"Zackheim","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.05.023_bib10","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.3747\/co.22.2287","article-title":"Use of the word \u201ccured\u201d for cancer patients\u2014implications for patients and physicians: the Siracusa charter","volume":"22","author":"Tralongo","year":"2015","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jaad.2018.05.023_bib11","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0190-9622(89)70051-7","article-title":"Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy and cutaneous T cell lymphoma","volume":"20","author":"Vonderheid","year":"1989","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.05.023_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0360-3016(98)00218-1","article-title":"Radiotherapy for unilesional mycosis fungoides","volume":"42","author":"Micaily","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.jaad.2018.05.023_bib13","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ejca.2006.01.025","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome","volume":"42","author":"Trautinger","year":"2006","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.jaad.2018.05.023_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/2013.jamadermatol.541","article-title":"Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides","volume":"149","author":"Lessin","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2018.05.023_bib15","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/archderm.141.9.1117","article-title":"Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study","volume":"141","author":"De Quatrebarbes","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2018.05.023_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archderm.139.2.165","article-title":"Topical nitrogen mustard in the management of mycosis fungoides. Update of the Stanford experience","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.05.023_bib17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2340\/0001555576475478","article-title":"PUVA in early mycosis fungoides may give long-term remission and delay extracutaneous spread","volume":"76","author":"Roupe","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2018.05.023_bib18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1067\/mjd.2001.110896","article-title":"'High-dose' UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides","volume":"44","author":"Zane","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.023_bib19","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0889-8588(03)00108-4","article-title":"Total skin electron beam radiotherapy for patients who have mycosis fungoides","volume":"17","author":"Jones","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"10.1016\/j.jaad.2018.05.023_bib20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/09546634.2012.735638","article-title":"Long-term follow-up of early mycosis fungoides patients treated with narrowband ultraviolet B phototherapy","volume":"25","author":"Elcin","year":"2014","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"10.1016\/j.jaad.2018.05.023_bib21","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.05.023_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jdermsci.2009.10.010","article-title":"Prognosis of 100 Japanese patients with mycosis fungoides and S\u00e9zary syndrome","volume":"57","author":"Suzuki","year":"2010","journal-title":"J Dermatol Sci"},{"issue":"31","key":"10.1016\/j.jaad.2018.05.023_bib23","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.jaad.2018.05.023_bib24","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","article-title":"Long-term outcomes of 1,263 patients with mycosis fungoides and Sezary syndrome from 1982 to 2009","volume":"18","author":"Talpur","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.jaad.2018.05.023_bib25","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0190-9622(99)70079-4","article-title":"Prognostic factor analysis in mycosis fungoides\/S\u00e9zary syndrome","volume":"40","author":"Diamandidou","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2018.05.023_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.140.9.1057","article-title":"Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas","volume":"140","author":"Tancr\u00e8de-Bohin","year":"2004","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.05.023_bib27","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/bjd.12909","article-title":"Prognostic factors, prognostic indices and staging in mycosis fungoides and S\u00e9zary syndrome: where are we now?","volume":"170","author":"Scarisbrick","year":"2014","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218308193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218308193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T19:44:33Z","timestamp":1693683873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218308193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0190962218308193"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.05.023","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential of narrow-band ultraviolet B to induce sustained durable complete remission off-therapy in patients with stage I mycosis fungoides","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}